Sale!

DMD Gene Cardiomyopathy dilated type 3B Genetic Test

Name: DMD Gene Cardiomyopathy dilated type 3B Genetic Test
SKU: TEST-3390
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “DMD Gene Cardiomyopathy Dilated Type 3B Genetic Test” is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the DMD gene, which are associated with dilated cardiomyopathy type 3B. This condition is a form of heart disease that affects the heart’s ability to pump blood efficiently, leading to enlargement of the heart’s chambers and weakened heart muscle. The test is particularly crucial for individuals with a family history of cardiomyopathy or those showing symptoms of heart muscle disease, as early detection can significantly impact management and treatment strategies. The test cost is set at 4400 AED, reflecting the advanced genetic analysis involved in identifying the specific mutations within the DMD gene. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of cardiomyopathy, enabling personalized treatment plans and potentially improving patient outcomes.

Description

DMD Gene Cardiomyopathy dilated type 3B Genetic Test

Components: DMD Gene Cardiomyopathy dilated type 3B Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for DMD Gene Cardiomyopathy, dilated type 3B NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DMD Gene Cardiomyopathy, dilated type 3B NGS Genetic DNA Test gene DMD

Test Details: DMD (Duchenne muscular dystrophy) gene cardiomyopathy, dilated type 3B is a genetic disorder characterized by the mutation in the DMD gene, which is responsible for producing a protein called dystrophin. This condition primarily affects the heart muscles, leading to the development of dilated cardiomyopathy. Dilated cardiomyopathy is a condition in which the heart becomes enlarged and weakened, leading to poor pumping of blood. Symptoms of this condition may include shortness of breath, fatigue, irregular heartbeats, and swelling in the legs and ankles. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of DMD gene cardiomyopathy, dilated type 3B, NGS genetic testing can identify mutations or variations in the DMD gene that may be responsible for the development of the condition. NGS genetic testing can help in the diagnosis of DMD gene cardiomyopathy, dilated type 3B by detecting specific mutations in the DMD gene. This information can be useful for healthcare providers in determining the appropriate treatment and management strategies for affected individuals. It is important to note that genetic testing should be conducted under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and interpretation of the results.

Test Name	DMD Gene Cardiomyopathy dilated type 3B Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for DMD Gene Cardiomyopathy, dilated type 3B NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DMD Gene Cardiomyopathy, dilated type 3B NGS Genetic DNA Test gene DMD
Test Details	DMD (Duchenne muscular dystrophy) gene cardiomyopathy, dilated type 3B is a genetic disorder characterized by the mutation in the DMD gene, which is responsible for producing a protein called dystrophin. This condition primarily affects the heart muscles, leading to the development of dilated cardiomyopathy. Dilated cardiomyopathy is a condition in which the heart becomes enlarged and weakened, leading to poor pumping of blood. Symptoms of this condition may include shortness of breath, fatigue, irregular heartbeats, and swelling in the legs and ankles. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of DMD gene cardiomyopathy, dilated type 3B, NGS genetic testing can identify mutations or variations in the DMD gene that may be responsible for the development of the condition. NGS genetic testing can help in the diagnosis of DMD gene cardiomyopathy, dilated type 3B by detecting specific mutations in the DMD gene. This information can be useful for healthcare providers in determining the appropriate treatment and management strategies for affected individuals. It is important to note that genetic testing should be conducted under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and interpretation of the results.